Evidence map›Paper›PMID 39458367›Full record

ArticleMicroorganisms2024

Ludwig Ermann Lundberg, Manuel Mata Forsberg, James Lemanczyk, Eva Sverremark-Ekström, Corine Sandström, Stefan Roos, Sebastian Håkansson

Abstract read
In one paragraph

Article in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ludwig Ermann LundbergDepartment of Molecular Sciences, Uppsala BioCenter, Swedish University of Agricultural Sciences, 750 07 Uppsala, Sweden.ORCID 0000-0001-5983-1771
Manuel Mata ForsbergThe Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, 114 18 Stockholm, Sweden.ORCID 0009-0008-3711-9722
James LemanczykBioGaia AB, 112 27 Stockholm, Sweden.
Eva Sverremark-EkströmThe Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, 114 18 Stockholm, Sweden.ORCID 0000-0001-6271-8681
Corine SandströmDepartment of Molecular Sciences, Uppsala BioCenter, Swedish University of Agricultural Sciences, 750 07 Uppsala, Sweden.ORCID 0000-0003-4219-9129
Stefan RoosDepartment of Molecular Sciences, Uppsala BioCenter, Swedish University of Agricultural Sciences, 750 07 Uppsala, Sweden.ORCID 0000-0002-1606-1794
Sebastian HåkanssonBioGaia AB, 112 27 Stockholm, Sweden.

Funding

Swedish Cancer Society 20 1117 PjF 01 HSwedish government LivsID (food-science related industry PhD program) N2017/03895Swedish Research Council 2020-01839
6 · The paper itself

Abstract

Improved efficacy of probiotics can be achieved by using different strategies, including the optimization of production parameters. The impact of fermentation parameters on bacterial physiology is a frequently investigated topic, but what happens during the formulation, i.e., the step where the lyoprotectants are added prior to freeze-drying, is less studied. In addition to this, the focus of process optimization has often been yield and stability, while effects on bioactivity have received less attention. In this work, we investigated different metabolic activities of the probiotic strain

Indexed as

exopolysaccharidesformulationimmunomodulationlyoconversionmetabolitesprobiotics

Identifiers

PMID39458367
PMCPMC11510291

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.